Media Release
Clinitech Laboratory Limited gets listed on BSE SME Platform
Mumbai, 01st August 2024: Clinitech Laboratory Limited became the 514th company to get listed on the BSE SME Platform on August 01, 2024 after successfully completing its public issue on July 29th.
Navi Mumbai registered Clinitech Laboratory Limited provides diagnostic and health testing and services. The company performs more than 150 tests in its centers, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests. Clinitech Laboratory has eight diagnostic centers around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.
For details on the issue, please visit https://www.bseindia.com/markets/publicIssues/DisplayIPO.aspx?id=3524&type=FPO&idtype=2&status=H&IPONo=6659&startdt=25-07-2024
About BSE
BSE (formerly Bombay Stock Exchange), which will celebrate its 150th year anniversary in July 2024, is Asia’s oldest and the world’s fastest Stock Exchange with a speed of 6 microseconds. India’s leading exchange group, BSE has been playing a prominent role in developing the Indian capital market. BSE is a corporatized and demutualized entity, with a broad shareholder base. BSE provides an efficient and transparent market for trading in equity, debt instruments, equity derivatives, currency derivatives, interest rate derivatives, mutual funds and stock lending and borrowing.
Media Contact
Santanu Chakraborty
022 2272 8516
Santanu.Chakraborty@bseindia.com